These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 17230639)
1. Mediation of adenylyl cyclase sensitization by PTX-insensitive GalphaoA, Galphai1, Galphai2 or Galphai3. Clark MJ; Traynor JR J Neurochem; 2006 Dec; 99(6):1494-504. PubMed ID: 17230639 [TBL] [Abstract][Full Text] [Related]
2. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells. Clark MJ; Traynor JR J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633 [TBL] [Abstract][Full Text] [Related]
3. Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. Avidor-Reiss T; Bayewitch M; Levy R; Matus-Leibovitch N; Nevo I; Vogel Z J Biol Chem; 1995 Dec; 270(50):29732-8. PubMed ID: 8530363 [TBL] [Abstract][Full Text] [Related]
4. Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins. Chan JS; Chiu TT; Wong YH J Neurochem; 1995 Dec; 65(6):2682-9. PubMed ID: 7595566 [TBL] [Abstract][Full Text] [Related]
5. Gi/o-coupled receptors compete for signaling to adenylyl cyclase in SH-SY5Y cells and reduce opioid-mediated cAMP overshoot. Levitt ES; Purington LC; Traynor JR Mol Pharmacol; 2011 Mar; 79(3):461-71. PubMed ID: 21098043 [TBL] [Abstract][Full Text] [Related]
6. Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways. Clark MJ; Harrison C; Zhong H; Neubig RR; Traynor JR J Biol Chem; 2003 Mar; 278(11):9418-25. PubMed ID: 12524446 [TBL] [Abstract][Full Text] [Related]
7. Endogenous regulators of G protein signaling differentially modulate full and partial mu-opioid agonists at adenylyl cyclase as predicted by a collision coupling model. Clark MJ; Linderman JJ; Traynor JR Mol Pharmacol; 2008 May; 73(5):1538-48. PubMed ID: 18285510 [TBL] [Abstract][Full Text] [Related]
8. Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling. Szücs M; Boda K; Gintzler AR J Pharmacol Exp Ther; 2004 Jul; 310(1):256-62. PubMed ID: 14996951 [TBL] [Abstract][Full Text] [Related]
9. Differential modulation of mu-opioid receptor signaling to adenylyl cyclase by regulators of G protein signaling proteins 4 or 8 and 7 in permeabilised C6 cells is Galpha subtype dependent. Talbot JN; Roman DL; Clark MJ; Roof RA; Tesmer JJ; Neubig RR; Traynor JR J Neurochem; 2010 Feb; 112(4):1026-34. PubMed ID: 20002516 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the relative efficacy and potency of mu-opioid agonists to activate Galpha(i/o) proteins containing a pertussis toxin-insensitive mutation. Clark MJ; Furman CA; Gilson TD; Traynor JR J Pharmacol Exp Ther; 2006 May; 317(2):858-64. PubMed ID: 16436499 [TBL] [Abstract][Full Text] [Related]
11. Endogenous regulator of G protein signaling proteins suppress Galphao-dependent, mu-opioid agonist-mediated adenylyl cyclase supersensitization. Clark MJ; Neubig RR; Traynor JR J Pharmacol Exp Ther; 2004 Jul; 310(1):215-22. PubMed ID: 15014136 [TBL] [Abstract][Full Text] [Related]
12. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain. Carter BD; Medzihradsky F Proc Natl Acad Sci U S A; 1993 May; 90(9):4062-6. PubMed ID: 8097884 [TBL] [Abstract][Full Text] [Related]
13. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits. Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820 [TBL] [Abstract][Full Text] [Related]
14. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. Liu JG; Prather PL Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600 [TBL] [Abstract][Full Text] [Related]
15. Distinct roles for Galphai2, Galphai3, and Gbeta gamma in modulation offorskolin- or Gs-mediated cAMP accumulation and calcium mobilization by dopamine D2S receptors. Ghahremani MH; Cheng P; Lembo PM; Albert PR J Biol Chem; 1999 Apr; 274(14):9238-45. PubMed ID: 10092597 [TBL] [Abstract][Full Text] [Related]
16. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells. Piros ET; Prather PL; Loh HH; Law PY; Evans CJ; Hales TG Mol Pharmacol; 1995 May; 47(5):1041-9. PubMed ID: 7746271 [TBL] [Abstract][Full Text] [Related]
17. Stimulation of cAMP synthesis by Gi-coupled receptors upon ablation of distinct Galphai protein expression. Gi subtype specificity of the 5-HT1A receptor. Liu YF; Ghahremani MH; Rasenick MM; Jakobs KH; Albert PR J Biol Chem; 1999 Jun; 274(23):16444-50. PubMed ID: 10347206 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling. Yabaluri N; Medzihradsky F Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981 [TBL] [Abstract][Full Text] [Related]
19. Sensitization of the adenylyl cyclase system in cloned kappa-opioid receptor-transfected cells following sustained agonist treatment: A chimeric study using G protein alpha(i)2/alpha(q) subunits. Nakagawa T; Ozawa T; Watanabe T; Minami M; Satoh M Jpn J Pharmacol; 1999 Dec; 81(4):353-61. PubMed ID: 10669040 [TBL] [Abstract][Full Text] [Related]
20. A conserved arginine in the distal third intracellular loop of the mu-opioid receptor is required for G protein activation. Wang HL J Neurochem; 1999 Mar; 72(3):1307-14. PubMed ID: 10037504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]